SCHEMBL14668355

SCHEMBL14668355

CCOC(=O)C(C)(CC)c1ccc(N)cn1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.41
CYP3A4 P08684 2/20 0.41
LMNA P02545 1/20 0.41
MAOA P21397 1/20 0.41
PDE4D Q08499 1/20 0.36
ALDH1A1 P00352 2/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
MMP8 P22894 1/20 0.36
TSHR P16473 2/20 0.36
MAPK1 P28482 1/20 0.36
ABCB11 O95342 1/20 0.35
HTR2A P28223 1/20 0.35
PMP22 Q01453 1/20 0.35
PPARA Q07869 1/20 0.35
PPIB P23284 1/20 0.35
PPIA P62937 1/20 0.35
PPID Q08752 1/20 0.35
PPIG Q13427 1/20 0.35
KCNQ3 O43525 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14659905 0.85 CYP2C19 (0.44) CYP1A2CYP3A4LMNAMAOAPDE4D
SCHEMBL14668358 0.80 CYP2C19 (0.59) CYP1A2LMNAALDH1A1KMT2ASMN1; SMN2
SCHEMBL2476201 0.77 MAPK1 (0.48) CYP1A2CYP3A4LMNAMAOAALDH1A1
SCHEMBL25512278 0.77 LMNA (0.44) LMNAALDH1A1MEN1KMT2AMMP8
SCHEMBL14668353 0.75 TSHR (0.37) CYP1A2CYP3A4LMNAMAOAALDH1A1
SCHEMBL11681491 0.73 RAB9A (0.44) LMNAALDH1A1KMT2AMMP8MAPK1
SCHEMBL17403411 0.71 RAB9A (0.42) LMNAALDH1A1MEN1KMT2ATSHR
SCHEMBL14595285 0.71 CNR2 (0.42) CYP1A2CYP3A4LMNAMAOAALDH1A1
SCHEMBL7627615 0.71 CYP2C19 (0.48) LMNAALDH1A1MEN1KMT2ATSHR
SCHEMBL15997340 0.70 CYP2C19 (0.37) KMT2ATSHRSMN1; SMN2KDM4ECYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130029961-A1 Substituted Heterocyclic Aza Compounds GRUENENTHAL GMBH (DE) 2013-01-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130029961-A1 Substituted Heterocyclic Aza Compounds TRPV1, GPR17, TRPV2 CYP1A2 1065/4885CYP3A4 673/4885LMNA 4204/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.